These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33201633)

  • 1. [Safe prescribing in patients with liver cirrhosis; 5 pitfalls].
    Weersink RA; Drenth JPH; Ter Borg F; Mulder MB; Taxis K; Borgsteede SD
    Ned Tijdschr Geneeskd; 2020 Oct; 164():. PubMed ID: 33201633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safe use of medication in patients with cirrhosis: pharmacokinetic and pharmacodynamic considerations.
    Weersink RA; Burger DM; Hayward KL; Taxis K; Drenth JPH; Borgsteede SD
    Expert Opin Drug Metab Toxicol; 2020 Jan; 16(1):45-57. PubMed ID: 31810397
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction.
    Verbeeck RK
    Eur J Clin Pharmacol; 2008 Dec; 64(12):1147-61. PubMed ID: 18762933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update.
    Morgan DJ; McLean AJ
    Clin Pharmacokinet; 1995 Nov; 29(5):370-91. PubMed ID: 8582120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug administration in chronic liver disease.
    Westphal JF; Brogard JM
    Drug Saf; 1997 Jul; 17(1):47-73. PubMed ID: 9258630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular drug therapy in patients with hepatic diseases and patients with congestive heart failure.
    Sokol SI; Cheng A; Frishman WH; Kaza CS
    J Clin Pharmacol; 2000 Jan; 40(1):11-30. PubMed ID: 10631618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An intensive drug monitoring study suggesting possible clinical irrelevance of impaired drug disposition in liver disease.
    Naranjo CA; Busto U; Janecek E; Ruiz I; Roach CA; Kaplan K
    Br J Clin Pharmacol; 1983 Apr; 15(4):451-8. PubMed ID: 6849781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward safer prescribing: evaluation of a prospective drug utilization review system on inappropriate prescriptions, prescribing patterns, and adverse drug events and related health expenditure in South Korea.
    Kim SJ; Han KT; Kang HG; Park EC
    Public Health; 2018 Oct; 163():128-136. PubMed ID: 30145461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacotherapy of cirrhosis: concerns and proposed investigations and solutions.
    Hilscher MB; Odell LJ; Myhre LJ; Prokop L; Talwalkar J
    J Clin Pharm Ther; 2016 Dec; 41(6):587-591. PubMed ID: 27576303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polypharmacy in chronic diseases-Reduction of Inappropriate Medication and Adverse drug events in older populations by electronic Decision Support (PRIMA-eDS): study protocol for a randomized controlled trial.
    Sönnichsen A; Trampisch US; Rieckert A; Piccoliori G; Vögele A; Flamm M; Johansson T; Esmail A; Reeves D; Löffler C; Höck J; Klaassen-Mielke R; Trampisch HJ; Kunnamo I
    Trials; 2016 Jan; 17():57. PubMed ID: 26822311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the safety and dosing of drugs in patients with liver cirrhosis by literature review and expert opinion.
    Weersink RA; Bouma M; Burger DM; Drenth JP; Hunfeld NG; Kranenborg M; Monster-Simons MH; van Putten SA; Metselaar HJ; Taxis K; Borgsteede SD
    BMJ Open; 2016 Oct; 6(10):e012991. PubMed ID: 27733414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-Based Recommendations to Improve the Safe Use of Drugs in Patients with Liver Cirrhosis.
    Weersink RA; Bouma M; Burger DM; Drenth JPH; Harkes-Idzinga SF; Hunfeld NGM; Metselaar HJ; Monster-Simons MH; Taxis K; Borgsteede SD
    Drug Saf; 2018 Jun; 41(6):603-613. PubMed ID: 29330714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: prescribing medications in patients with cirrhosis - a practical guide.
    Lewis JH; Stine JG
    Aliment Pharmacol Ther; 2013 Jun; 37(12):1132-56. PubMed ID: 23638982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using a clinical process map to identify prescribing cascades in your patient.
    Piggott KL; Mehta N; Wong CL; Rochon PA
    BMJ; 2020 Feb; 368():m261. PubMed ID: 32075785
    [No Abstract]   [Full Text] [Related]  

  • 15. [Polymedication among elderly patients Preventing drug related problems and inappropriate medication].
    Patris S
    J Pharm Belg; 2016 Sep; (3):4-9. PubMed ID: 30281238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collaborative approach to Optimise MEdication use for Older people in Nursing homes (COME-ON): study protocol of a cluster controlled trial.
    Anrys P; Strauven G; Boland B; Dalleur O; Declercq A; Degryse JM; De Lepeleire J; Henrard S; Lacour V; Simoens S; Speybroeck N; Vanhaecht K; Spinewine A; Foulon V
    Implement Sci; 2016 Mar; 11():35. PubMed ID: 26968520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescribing cascades in older adults.
    Sternberg SA; Guy-Alfandary S; Rochon PA
    CMAJ; 2021 Feb; 193(6):E215. PubMed ID: 33558408
    [No Abstract]   [Full Text] [Related]  

  • 18. Frailty, polypharmacy and deprescribing.
    Drug Ther Bull; 2016 Jun; 54(6):69-72. PubMed ID: 27284125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods to reduce prescribing errors in elderly patients with multimorbidity.
    Lavan AH; Gallagher PF; O'Mahony D
    Clin Interv Aging; 2016; 11():857-66. PubMed ID: 27382268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inappropriate prescribing in the elderly].
    Pepersack T
    Rev Med Brux; 2013 Sep; 34(4):295-300. PubMed ID: 24195243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.